Preventing False Discovery of Heterogeneous Treatment Effect Subgroups in Randomized Trials

Trials - United Kingdom
doi 10.1186/s13063-018-2774-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Role of Vitamin K2 in Preventing the Recurrence of Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis of Randomized Controlled Trials

BMC Gastroenterology
MedicineGastroenterology
2012English

Assessing Heterogeneity of Treatment Effect Analyses in Health-Related Cluster Randomized Trials: A Systematic Review

PLoS ONE
Multidisciplinary
2019English

Effect of Atorvastatin Treatment on Circulating Adiponectin: A Meta-Analysis of Randomized Controlled Trials

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2019English

Avoiding False Discovery in Biomarker Research

BMC Biochemistry
BiochemistryMolecular Biology
2016English

Efficacy and Safety of Ondansetron in Preventing Postanesthesia Shivering: A Meta-Analysis of Randomized Controlled Trials

BMC Anesthesiology
AnesthesiologyPain Medicine
2014English

Effect Sizes in Ongoing Randomized Controlled Critical Care Trials

Critical Care
Critical CareIntensive Care Medicine
2017English

False Dichotomies and Health Policy Research Designs: Randomized Trials Are Not Always the Answer

Journal of General Internal Medicine
Internal Medicine
2016English

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials

Headache
Neurology
2019English

Biases in Randomized Trials

Epidemiology
Epidemiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy